证券代码：603639 证券简称：海利尔 公告编号：2025-040 海利尔药业集团股份有限公司 关于为全资子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | | | 被担保人名称 | 山东海利尔化工有限公司（以下简 称"山东海利尔"） | | | | --- | --- | --- | --- | --- | --- | | | | | 万元 | | | | 担 保 | 对 | 本次担保金额 | 15,000.00 | | | | 象一 | | 实际为其提供的担保余额 | 25,597.03 万元 | | | | | | 是否在前期预计额度内 | | 是 □否 | □不适用：_________ | | | | 本次担保是否有反担保 | | □是 否 | □不适用：_________ | | | | 被担保人名称 | 下简称"奥迪斯"） | | 青岛奥迪斯生物科技有限公司（以 | | 担 保 | 对 | 本次担保金额 | 10,000.00 | | 万元 | | 象二 | | 实际 ...

Investment Rating - The report maintains a "Recommended" rating for the basic chemical industry [1] Core Insights - The report highlights the price increases of lithium carbonate and photoinitiators, suggesting a potential recovery in the chemical industry driven by anti-involution trends [1] - The basic chemical sector has shown strong relative performance, with a 39.4% increase over the past 12 months compared to the 25.7% increase in the CSI 300 index [3] Summary by Sections Recent Trends - The report notes a decline in the Guohai Chemical Prosperity Index to 92.75 as of August 14, 2025, down 0.11 from August 7, 2025 [4] Investment Recommendations - Key opportunities identified include: 1. Low-cost expansion in companies such as Wanhua Chemical, Satellite Chemical, and others [5] 2. Improvement in industry prosperity for chromium salts, phosphate rock, and various chemical sectors [6] 3. Focus on new materials with high growth potential and low domestic substitution rates [7] 4. High dividend opportunities in state-owned enterprises like China Petroleum and Sinopec [8] Price Analysis of Key Products - Industrial-grade lithium carbonate price increased by 9.93% to 83,000 CNY/ton [10] - Photoinitiator (TPO) price rose by 5.56% to 95 CNY/kg [10] - Polyester filament price increased by 2.16% to 7,100 CNY/ton [10] Company Performance Tracking - Notable companies such as Zhenhua Co. reported a 10.17% increase in revenue for the first half of 2025 [13] - Wanhua Chemical's pure MDI price was reported at 17,900 CNY/ton, with a slight increase [11] Market Observations - The report indicates a potential inventory replenishment cycle in the chemical sector due to anticipated fiscal policy support in China and the US [29]

证券代码：603639 证券简称：海利尔 公告编号：2025-039 海利尔药业集团股份有限公司 为保障公司董事会正常运作，根据《公司法》《上海证券交易所股票上市规则》 《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等法律法规、规范 性文件以及《公司章程》等相关规定，公司于 2025 年 8 月 13 日召开 2025 年第一次 职工代表大会，选举陈萍先生为公司第五届董事会职工代表董事（简历详见附件）， 任期自本次职工代表大会审议通过之日起至公司第五届董事会届满之日止。 陈萍先生当选公司职工代表董事后，公司第五届董事会中兼任公司高级管理人 员以及由职工代表担任的董事人数总计未超过公司董事总数的二分之一，符合相关 法律法规的要求。 特此公告。 海利尔药业集团股份有限公司董事会 2025 年 8 月 14 日 附件： 关于公司董事辞任暨选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 海利尔药业集团股份有限公司（以下简称"公司"）董事会于近日收到公司董 事毛志建先生递交的书面辞职报告。因公司内部 ...

Group 1 - The company has products, specifically the raw materials imidacloprid and thiamethoxam, that have a certain effectiveness in killing mosquitoes [2] - The Qingdao Hengning project, which will produce 1,500 tons of thiamethoxam annually, is set to enter trial production in December 2024 [2] - The combined sales revenue from imidacloprid and thiamethoxam raw materials is expected to account for less than 10% of the company's total revenue in 2024 [2]

Group 1 - The company is actively engaged in research and promotion of biopesticides and fertilizers [2]

Core Viewpoint - The company plans to repurchase and cancel 20,000 restricted stocks due to certain incentive recipients no longer meeting the eligibility criteria outlined in the 2021 restricted stock incentive plan [2][4]. Group 1: Repurchase and Cancellation Details - The decision for the repurchase and cancellation of restricted stocks was approved during the fifth board meeting on April 28, 2025, following the authorization from the first extraordinary general meeting of shareholders in 2021 [2][4]. - The repurchase involves 6 incentive recipients who will have their unvested restricted stocks canceled [5]. - The company has opened a dedicated securities account for the repurchase and submitted the application for cancellation, expecting to complete the process by August 1, 2025 [5]. Group 2: Legal and Compliance Aspects - The board confirms that the decision-making process and information disclosure comply with relevant laws and regulations, ensuring no harm to the rights of incentive recipients or creditors [7]. - A legal opinion from a law firm confirms that the repurchase has obtained necessary authorizations and complies with applicable laws and regulations [7].

证券代码：603639 证券简称：海利尔 公告编号：2025-038 海利尔药业集团股份有限公司 关于股权激励限制性股票回购注销实施的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购注销原因：根据公司 2021 年限制性股票激励计划相关规定，公司部 分激励对象已不符合激励条件，公司拟对该激励对象已获授但尚未解锁的限制性 股票进行回购注销。 本次注销股份的有关情况： | 回购股份数量 | 注销股份数量 | 注销日期 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 20,000 | 股 | 20,000 | 股 | 2025 | 年 | 8 | 月 | 1 | 日 | 一、本次限制性股票回购注销的决策与信息披露 根据公司 2021 年第一次临时股东大会的授权，2025 年 4 月 28 日，公司召 开第五届董事会第八次会议和第五届监事会第八次会议，审议通过《关于回购注 销部分激励对象已获授但尚未 ...

北京市金杜（青岛）律师事务所 关于海利尔药业集团股份有限公司 2021 年限制性股票激励计划回购注销部分已授予限制性股票事项的 法律意见书 致：海利尔药业集团股份有限公司 北京市金杜（青岛）律师事务所（以下简称金杜或本所）受海利尔药业集团 股份有限公司（以下简称海利尔或公司）委托，作为其 2021 年限制性股票激励计 划（以下简称本次股权激励计划或本计划）的专项法律顾问。本所根据《中华人 民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简称《证 券法》）、中国证券监督管理委员会（以下简称中国证监会）《上市公司股权激励管 理办法》（以下简称《管理办法》）1等法律、行政法规、部门规章及规范性文件（以 下简称法律法规）和《海利尔药业集团股份有限公司章程》（以下简称《公司章程》） 的有关规定，以及公司于 2021 年 3 月 6 日公告的《海利尔药业集团股份有限公司 2021 年限制性股票激励计划（草案）》（以下简称《限制性股票激励计划》），就公 司本次回购注销部分已授予限制性股票（以下简称本次回购注销）所涉及的相关 事宜出具本法律意见书。 为出具本法律意见书，金杜依据《律师事务所从事证券法律业 ...

Market Overview - The agricultural chemical sector experienced a decline of 0.23% on July 29, with Hai Li Er leading the drop [1] - The Shanghai Composite Index closed at 3609.71, up 0.33%, while the Shenzhen Component Index closed at 11289.41, up 0.64% [1] Stock Performance - Notable gainers in the agricultural chemical sector included: - Yabao Chemical (300261) with a closing price of 8.12, up 7.12% and a trading volume of 976,500 shares, totaling 776 million yuan [1] - Bai Ao Chemical (603360) closed at 20.28, up 4.11% with a trading volume of 239,600 shares, totaling 476 million yuan [1] - Conversely, Hai Li Er (603639) saw a significant decline, closing at 14.80, down 6.03% with a trading volume of 212,400 shares, totaling 314 million yuan [2] Capital Flow - The agricultural chemical sector experienced a net outflow of 577 million yuan from institutional investors, while retail investors saw a net inflow of 518 million yuan [2] - The capital flow for key stocks showed: - Yabao Chemical had a net inflow of 11.56 million yuan from institutional investors, but a net outflow from retail investors of 73.06 million yuan [3] - Hai Li Er had a net inflow of 28.38 million yuan from institutional investors, but a significant net outflow of 45.61 million yuan from retail investors [3]

Core Viewpoint - The company has announced the provision of guarantees for its wholly-owned subsidiaries, Qingdao Hengning Biotechnology Co., Ltd. and Shandong Hailier Chemical Co., Ltd., totaling RMB 150 million to support their credit activities [1][2][8]. Group 1: Guarantee Details - The total guarantee amount for Qingdao Hengning Biotechnology is RMB 50 million, with no prior guarantee balance [1][2]. - The total guarantee amount for Shandong Hailier is RMB 100 million, with an existing guarantee balance of RMB 270.6358 million [1][2]. - The guarantees are within the previously estimated limits and do not require counter-guarantees [1][2]. Group 2: Subsidiary Information - Qingdao Hengning Biotechnology is a wholly-owned subsidiary with a registered capital of RMB 116.66 million, established on July 24, 2019, and focuses on technology services and chemical product production [3][4]. - Shandong Hailier Chemical is also a wholly-owned subsidiary with a registered capital of RMB 51.66 million, established on December 17, 2007, and engages in pesticide production and chemical sales [3][4]. Group 3: Financial Overview - As of the latest audited financials, the total external guarantee amount by the company and its subsidiaries is RMB 3.331 billion, representing 97.29% of the company's audited net assets as of December 31, 2024 [8]. - Both subsidiaries, Hengning and Shandong Hailier, are not classified as dishonest executors [5]. Group 4: Board Decisions - The board of directors approved the proposal for the company to apply for a comprehensive credit limit for 2025 and to provide corresponding guarantee limits during the meetings held on April 28, 2025 [7][8]. - The guarantees are deemed necessary to support the subsidiaries' business development and ensure stable operations, aligning with the company's overall interests and strategic development [7].